The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 19, 2021
Filed:
Mar. 17, 2020
Applicant:
Advantage Therapeutics, Inc., Fort Lauderdale, FL (US);
Inventors:
Markus Mandler, Vienna, AT;
Achim Schneeberger, Vienna, AT;
Frank Mattner, Vienna, AT;
Walter Schmidt, Vienna, AT;
Assignee:
Advantage Therapeutics, Inc., Fort Lauderdale, FL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/00 (2006.01); A61K 33/06 (2006.01); A61K 9/00 (2006.01); A61K 47/02 (2006.01); A61K 33/08 (2006.01); A61K 38/03 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 9/0019 (2013.01); A61K 33/06 (2013.01); A61K 33/08 (2013.01); A61K 38/03 (2013.01); A61K 39/0007 (2013.01); A61K 47/02 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/6081 (2013.01);
Abstract
Disclosed is a method for the treatment of AD, wherein an immune stimulating pharmaceutical composition comprising an aluminium salt is administered to a patient having AD or having a risk to develop AD in an effective amount.